SMBC Nikko’s planned merger with Jefferies may extend beyond equities to other investment banking areas, its CEO said https://t.co/FDCRdf5kuv ...

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Evercore (EVR) due to higher revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Evercore is expected to report quarterly earnings of $2.87 per share, reflecting a year-over-year increase of +40.7% [3]. - Revenues are projected to be $899.29 million, which is a 21.6% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 1.2% over the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Evercore is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +12.21%, suggesting a bullish outlook from analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10]. - Evercore currently holds a Zacks Rank of 3, indicating a likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Evercore exceeded the expected earnings of $1.78 per share by delivering $2.42, resulting in a surprise of +35.96% [13]. - Over the past four quarters, Evercore has consistently beaten consensus EPS estimates [14]. Conclusion - Evercore is positioned as a compelling candidate for an earnings beat, but investors should consider additional factors before making investment decisions [17].

Market Overview - Major stock indices have shown strong upward movement, with the Nasdaq up 296.91 points (1.3%), S&P 500 up 67.24 points (1.0%), and Dow up 290.89 points (0.6%) [1] Company Earnings - Morgan Stanley's shares surged by 7.2% after reporting better than expected third quarter results [2] - Bank of America also saw a 5.2% increase in shares following third quarter results that exceeded analyst estimates [2] - ASML reported mixed third quarter results but expects 2026 total net sales to exceed 2025, leading to significant strength in its U.S.-listed shares [3] - Abbott Laboratories faced pressure on its shares after reporting weaker than expected third quarter revenues [3] Economic Indicators - The New York Fed's general conditions index rose to a positive 10.7 in October, a significant turnaround from a negative 8.7 in September, indicating growth [5] Sector Performance - Gold stocks have risen sharply, with the NYSE Arca Gold Bugs Index up 3.3% to a record intraday high [6] - Computer hardware and semiconductor stocks also showed substantial strength, with the NYSE Arca Computer Hardware Index and the Philadelphia Semiconductor Index up 3.3% and 2.9%, respectively [6] - Brokerage, networking, and telecom stocks are experiencing significant strength, moving higher along with most major sectors [7] International Markets - In the Asia-Pacific region, stocks moved mostly higher, with Japan's Nikkei 225 Index up 1.8% and China's Shanghai Composite Index up 1.2% [8] - European markets showed mixed performance, with the U.K.'s FTSE 100 Index down 0.1%, while the German DAX Index remained stable and the French CAC 40 Index rose by 2.2% [8] Bond Market - Treasuries are showing modest strength, with the yield on the benchmark ten-year note down by 1.3 basis points at 4.009% [9]

And let's get right to the banks with Bank of America and Morgan Stanley headlining today's results. Some stellar performance now that the market has opened as well. Morgan Stanley up nearly 7%.That call is still ongoing. Uh Ted Pick was just talking about the golden age of investment banking which I think you can see really reflected in these results. They beat on all metrics essentially except for expenses.But you know in terms of their three major businesses big beats relative to expectations. Investment ...

Third Quarter 2025 Earnings Results - Firm compensation expenses excluding DCP, which represents a non-GAAP financial measure, were: 3Q25: $7,142 million, 2Q25: $6,819 million, 3Q24: $6,457 million, 3Q25 YTD: $21,484 million, 3Q24 YTD: $19,309 million. - The End Notes are an integral part of this presentation. See pages 12 - 17 for Definition of U.S. GAAP to Non-GAAP Measures, Definitions of Performance Metrics and Terms, Supplemental Quantitative Details and Calculations, and Legal Notice. Consolidated Fin ...

JPMorgan is selling investment-grade bonds in three parts on Wednesday, joining rival Goldman Sachs in raising debt after reporting third-quarter earnings https://t.co/CY0ot8TBrl ...

Core Insights - Goldman Sachs recognized Jonathan Swerdlin, Co-Founder & CEO of Function Health, as one of the Most Exceptional Entrepreneurs of 2025 at the Builders and Innovators Summit [1][2][3] Company Overview - Function Health is a proactive healthcare platform providing access to over 100 lab tests and advanced MRI and CT imaging powered by FDA-cleared AI, aimed at early disease detection [2][4] - The platform offers comprehensive health insights for $499 per year, which is significantly more than the average 19 lab tests provided in a typical physical examination [4] Market Position - Function Health has attracted nearly 200,000 members since mid-2023, indicating strong market interest and growth potential [4] - The Builders and Innovators Summit is a prestigious event that has previously honored entrepreneurs who have led multi-billion dollar companies, highlighting the potential for Function Health's future success [3] Leadership Recognition - Jonathan Swerdlin expressed that being recognized by Goldman Sachs validates Function's mission to empower individuals to live healthier lives [3] - David Solomon, Chairman and CEO of Goldman Sachs, acknowledged Function Health's role in redefining industry paradigms and leveraging AI for business innovation [3]

Morgan Stanley’s stock traders crushed expectations in the third quarter, topping rivals on the surge in trading activity as US President Donald Trump’s policies kept markets jittery throughout the period https://t.co/M65HU3R8Fi ...

Core Insights - Morgan Stanley's profit increased significantly in the third quarter, driven by higher fees from advisory services and underwriting activities [1] Group 1: Financial Performance - The profit surge was attributed to investment bankers generating more fees from advising on deals [1] - Underwriting of stock and debt sales also contributed to the increased revenue [1]

Core Insights - The article discusses the importance of accessing investment portfolios for effective management and decision-making [1] Group 1 - The need for secure sign-in processes to protect sensitive financial information [1]